Dear readers, I hope the end of 2024 left you in high spirits. As we start a new year, I want to capitalize on that…

Hello readers, Fall brought much-needed cooler temperatures in the Northern Hemisphere and the ASH annual meeting is just around the corner. Before the big release…

Greetings, my dear readers, Today’s newsletter is all about mutations and how they define certain subsets of MDS and CHIP. The first couple of articles…

Dear readers, In this edition of the MDS newsletter, I cover a diverse spectrum of presentations from pre-MDS CCUS to allogenic transplants in MDS. Let’s…

Dear readers, This version of my MDS newsletter is focused on low-risk MDS. Much of the recent development in the field of MDS has been…

Dear readers, I want to start this newsletter by thanking you for taking time from your busy schedules to read about the latest and greatest…

Dear readers, March ushers in spring for those of us in the northern hemisphere. This month’s newsletter features 2 articles about the post-transplant setting in…

Happy New Year everyone!  I hope 2024 brings exciting news for our patients with myelodysplastic syndromes (MDS), especially those with high-risk disease and TP53 mutations.…